| Chronic cerebral lipocalin 2 exposure elicits hippocampal neuronal dysfunction and cognitive impairment B Olson, X Zhu, MA Norgard, P Diba, PR Levasseur, AC Buenafe, ... Brain, behavior, and immunity 97, 102-118, 2021 | 34 | 2021 |
| GoPeaks: histone modification peak calling for CUT&Tag WM Yashar, G Kong, J VanCampen, BM Curtiss, DJ Coleman, L Carbone, ... Genome biology 23 (1), 144, 2022 | 32 | 2022 |
| Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms SA Carratt, GL Kong, BM Curtiss, Z Schonrock, L Maloney, BN Maniaci, ... Blood, The Journal of the American Society of Hematology 140 (6), 644-658, 2022 | 17 | 2022 |
| Cell-type-specific responses to the microbiota across all tissues of the larval zebrafish MS Massaquoi, GL Kong, D Chilin-Fuentes, JS Ngo, PF Horve, ... Cell reports 42 (2), 2023 | 7 | 2023 |
| PU. 1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia BM Curtiss, J VanCampen, J Macaraeg, GL Kong, A Taherinasab, ... Leukemia 36 (7), 1781-1793, 2022 | 6 | 2022 |
| Disruption of the MYC superenhancer complex by dual targeting of FLT3 and LSD1 in acute myeloid leukemia WM Yashar, BM Curtiss, DJ Coleman, J VanCampen, G Kong, ... Molecular Cancer Research 21 (7), 631-647, 2023 | 4 | 2023 |
| Global host responses to the microbiota at single cell resolution in gnotobiotic zebrafish MS Massaquoi, G Kong, D Chilin, MK Hamilton, E Melancon, JS Eisen, ... BioRXiv, 2022.03. 28.486083, 2022 | 4 | 2022 |
| PU. 1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia BM Smith, J VanCampen, GL Kong, W Yashar, YH Tsang, W Horton, ... BioRxiv, 2021.08. 24.456354, 2021 | 4 | 2021 |
| RUNX1::ETO translocations must precede CSF3R mutations to promote acute myeloid leukemia development SA Carratt, GL Kong, C Coblentz, Z Schonrock, L Maloney, B Weeder, ... Leukemia 37 (5), 1141-1146, 2023 | 2 | 2023 |
| FLT3 and LSD1 Inhibitor Combinations Synergistically Repress Growth of FLT3-Mutant Acute Myeloid Leukemia Via Blockage of MYC Function DJ Coleman, BM Smith, C Coblentz, RL Callahan, J VanCampen, ... Blood 136, 31-32, 2020 | 2 | 2020 |
| Oncogenic SETBP1 Mutations Combine with Activating Mutations in CSF3R to Produce a Highly Proliferative, Lethal Leukemia through Aberrant Myc Signaling SA Carratt, TP Braun, Z Schonrock, BM Smith, DJ Coleman, G Kong, ... Blood 136, 51-52, 2020 | 2 | 2020 |
| CITE-Viz: Replicating the Interactive Flow Cytometry Workflow in CITE-Seq GL Kong, TT Nguyen, WK Rosales, AD Panikar, JHW Cheney, BM Curtiss, ... bioRxiv, 2022.05. 15.491411, 2022 | 1 | 2022 |
| CITEViz: interactively classify cell populations in CITE-Seq via a flow cytometry-like gating workflow using R-Shiny GL Kong, TT Nguyen, WK Rosales, AD Panikar, JHW Cheney, TA Lusardi, ... BMC bioinformatics 25 (1), 142, 2024 | | 2024 |
| Large-scale CyTOF data modeling of leukemia patient cohorts G Kong, T Vu, E Lind, OH Nikolova Cancer Research 84 (6_Supplement), 4961-4961, 2024 | | 2024 |
| A framework for considering prior information in network‐based approaches to omics data analysis J Somers, M Fenner, G Kong, D Thirumalaisamy, WM Yashar, K Thapa, ... Proteomics 23 (21-22), 2200402, 2023 | | 2023 |
| 3047–ROLE OF EPIGENETIC DYSFUNCTION IN CHRONIC NEUTROPHILIC LEUKEMIA L Darmusey, A Bagley, H Blaylock, A Foley, T Nguyen, K Nino, G Kong, ... Experimental Hematology 124, S73, 2023 | | 2023 |
| Dual targeting of FLT3 and LSD1 disrupts the MYC super-enhancer complex in acute myeloid leukemia W Yashar, BM Smith, DJ Coleman, J VanCampen, G Kong, J Macaraeg, ... bioRxiv, 2022.01. 17.476469, 2022 | | 2022 |
Hunter Z BlaylockGraduate Student at the University of Chicago在 uchicago.edu 的电子邮件经过验证
